PDE5A and neoplasm: In this study, we constructed a Meo-PEG-S–S-PLGA-based reduction-responsive nanoplatforms capable of delivering circPDE5A and PDE5A-500aa overexpression plasmids to tumor cells, which can successfully inhibit ESCC growth and metastasis in vivo.